Related Experiment Videos
Pentobarbitone inhibition of catecholamine secretion
British Journal of Pharmacology
|October 1, 1973
Summary
Pentobarbitone inhibits catecholamine secretion by affecting chromaffin cell membranes, impacting exocytosis triggered by various stimulants. This effect was not observed with all secretagogues or isolated vesicles.
Area of Science:
- Pharmacology
- Neuroendocrinology
- Cell Biology
Background:
- The adrenal medulla is crucial for catecholamine release.
- Understanding modulators of catecholamine secretion is vital for physiological and pharmacological research.
Purpose of the Study:
- To investigate the effects of barbituric acid, phenobarbitone, and pentobarbitone on catecholamine secretion from isolated cow adrenal glands.
- To elucidate the mechanism by which pentobarbitone inhibits catecholamine release.
Main Methods:
- Utilized a perfused isolated cow adrenal gland model.
- Administered various secretagogues (acetylcholine, carbachol, histamine, (+)-amphetamine, potassium chloride, acetaldehyde, calcium chloride, tyramine) to stimulate catecholamine release.
- Assessed the inhibitory effects of barbituric acid, phenobarbitone, and pentobarbitone on catecholamine secretion.
- Examined the impact of pentobarbitone on catecholamine release from isolated chromaffin vesicles.
Main Results:
- Pentobarbitone significantly inhibited catecholamine secretion induced by exocytosis-causing drugs, with varying effective concentrations.
- The inhibitory effect of pentobarbitone was independent of the secretagogue concentration.
- Pentobarbitone did not inhibit catecholamine release induced by acetaldehyde or calcium chloride, and only slightly inhibited tyramine-induced release.
- Phenobarbitone inhibited carbachol-induced catecholamine release, while barbituric acid had no effect.
- Pentobarbitone did not affect spontaneous or drug-induced catecholamine release from isolated chromaffin vesicles.
Conclusions:
- Pentobarbitone inhibits catecholamine release by interfering with a necessary configurational change in the chromaffin cell membrane structure.
- This mechanism links receptor activation to catecholamine release, suggesting a specific site of action for pentobarbitone.
- The findings differentiate the action of pentobarbitone from other barbiturates and highlight its specific role in modulating adrenal medulla function.